Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001202745 | SCV001373871 | likely benign | Duchenne muscular dystrophy | 2024-08-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812246 | SCV002050039 | uncertain significance | not provided | 2021-03-10 | criteria provided, single submitter | clinical testing | The DMD c.2780C>T; p.Ala927Val variant (rs41312094), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 934369). This variant is found in the non-Finnish European population with an allele frequency of .0043% (4/92234 alleles, including 2 hemizygotes) in the Genome Aggregation Database. The alanine at codon 927 is moderately conserved, but computational analyses predict that this variant is neutral (REVEL: 0.027). However, given the lack of clinical and functional data, the significance of the p.Ala927Val variant is uncertain at this time. |
Ambry Genetics | RCV004609653 | SCV005108240 | likely benign | Cardiovascular phenotype | 2024-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828627 | SCV002089674 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-07-12 | no assertion criteria provided | clinical testing |